Alto Neuroscience Statistics

Total Valuation

ANRO has a market cap or net worth of $62.54 million. The enterprise value is -$68.26 million.

Market Cap	62.54M
Enterprise Value	-68.26M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ANRO has 27.07 million shares outstanding. The number of shares has increased by 274.08% in one year.

Current Share Class	27.07M
Shares Outstanding	27.07M
Shares Change (YoY)	+274.08%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	8.24%
Owned by Institutions (%)	56.88%
Float	17.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.45
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.53, with a Debt / Equity ratio of 0.19.

Current Ratio	22.53
Quick Ratio	22.15
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.96

Financial Efficiency

Return on equity (ROE) is -38.04% and return on invested capital (ROIC) is -23.70%.

Return on Equity (ROE)	-38.04%
Return on Assets (ROA)	-22.88%
Return on Invested Capital (ROIC)	-23.70%
Return on Capital Employed (ROCE)	-42.45%
Revenue Per Employee	n/a
Profits Per Employee	-$831,355
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-76.81%
50-Day Moving Average	2.45
200-Day Moving Average	4.77
Relative Strength Index (RSI)	44.39
Average Volume (20 Days)	411,903

Short Selling Information

The latest short interest is 2.79 million, so 10.32% of the outstanding shares have been sold short.

Short Interest	2.79M
Short Previous Month	3.01M
Short % of Shares Out	10.32%
Short % of Float	15.60%
Short Ratio (days to cover)	11.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-69.90M
Pretax Income	n/a
Net Income	-63.18M
EBITDA	-69.32M
EBIT	-69.90M
Earnings Per Share (EPS)	-$2.34

Full Income Statement

Balance Sheet

The company has $160.75 million in cash and $26.44 million in debt, giving a net cash position of $134.32 million or $4.96 per share.

Cash & Cash Equivalents	160.75M
Total Debt	26.44M
Net Cash	134.32M
Net Cash Per Share	$4.96
Equity (Book Value)	139.10M
Book Value Per Share	5.14
Working Capital	156.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.00 million and capital expenditures -$1.88 million, giving a free cash flow of -$54.87 million.

Operating Cash Flow	-53.00M
Capital Expenditures	-1.88M
Free Cash Flow	-54.87M
FCF Per Share	-$2.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-274.08%
Shareholder Yield	-274.08%
Earnings Yield	-95.65%
FCF Yield	-83.07%

Analyst Forecast

The average price target for ANRO is $10.40, which is 350.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.40
Price Target Difference	350.22%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1